335 related articles for article (PubMed ID: 26844685)
1. Technology Access and Smartphone App Preferences for Medication Adherence in Adolescents and Young Adults With Sickle Cell Disease.
Badawy SM; Thompson AA; Liem RI
Pediatr Blood Cancer; 2016 May; 63(5):848-52. PubMed ID: 26844685
[TBL] [Abstract][Full Text] [Related]
2. Adherence to hydroxyurea, health-related quality of life domains and attitudes towards a smartphone app among Irish adolescents and young adults with sickle cell disease.
Fogarty H; Gaul A; Syed S; Aleksejenko N; Geoghegan R; Conroy H; Crampton E; Ngwenya N; Tuohy E; McMahon C
Ir J Med Sci; 2022 Apr; 191(2):809-816. PubMed ID: 33745105
[TBL] [Abstract][Full Text] [Related]
3. Development of the InCharge Health Mobile App to Improve Adherence to Hydroxyurea in Patients With Sickle Cell Disease: User-Centered Design Approach.
Alberts NM; Badawy SM; Hodges J; Estepp JH; Nwosu C; Khan H; Smeltzer MP; Homayouni R; Norell S; Klesges L; Porter JS; Hankins JS
JMIR Mhealth Uhealth; 2020 May; 8(5):e14884. PubMed ID: 32383683
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life and adherence to hydroxyurea in adolescents and young adults with sickle cell disease.
Badawy SM; Thompson AA; Lai JS; Penedo FJ; Rychlik K; Liem RI
Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27896936
[TBL] [Abstract][Full Text] [Related]
5. Adherence to hydroxyurea, health-related quality of life domains, and patients' perceptions of sickle cell disease and hydroxyurea: a cross-sectional study in adolescents and young adults.
Badawy SM; Thompson AA; Lai JS; Penedo FJ; Rychlik K; Liem RI
Health Qual Life Outcomes; 2017 Jul; 15(1):136. PubMed ID: 28679417
[TBL] [Abstract][Full Text] [Related]
6. Barriers to hydroxyurea adherence and health-related quality of life in adolescents and young adults with sickle cell disease.
Badawy SM; Thompson AA; Penedo FJ; Lai JS; Rychlik K; Liem RI
Eur J Haematol; 2017 Jun; 98(6):608-614. PubMed ID: 28306171
[TBL] [Abstract][Full Text] [Related]
7. A Multidimensional Electronic Hydroxyurea Adherence Intervention for Children With Sickle Cell Disease: Single-Arm Before-After Study.
Creary S; Chisolm D; Stanek J; Hankins J; O'Brien SH
JMIR Mhealth Uhealth; 2019 Aug; 7(8):e13452. PubMed ID: 31397291
[TBL] [Abstract][Full Text] [Related]
8. Access to Technology and Preferences for an mHealth Intervention to Promote Medication Adherence in Pediatric Acute Lymphoblastic Leukemia: Approach Leveraging Behavior Change Techniques.
Heneghan MB; Hussain T; Barrera L; Cai SW; Haugen M; Morgan E; Rossoff J; Weinstein J; Hijiya N; Cella D; Badawy SM
J Med Internet Res; 2021 Feb; 23(2):e24893. PubMed ID: 33599621
[TBL] [Abstract][Full Text] [Related]
9. A pilot study of electronic directly observed therapy to improve hydroxyurea adherence in pediatric patients with sickle-cell disease.
Creary SE; Gladwin MT; Byrne M; Hildesheim M; Krishnamurti L
Pediatr Blood Cancer; 2014 Jun; 61(6):1068-73. PubMed ID: 24436121
[TBL] [Abstract][Full Text] [Related]
10. Adherence to Hydroxyurea and Patients' Perceptions of Sickle Cell Disease and Hydroxyurea: A Cross-Sectional Study.
Madkhali MA; Abusageah F; Hakami F; Zogel B; Hakami KM; Alfaifi S; Alhazmi E; Zaalah S; Trabi S; Alhazmi AH; Mohrag M; Malhan H
Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38256385
[No Abstract] [Full Text] [Related]
11. Improving Medication Adherence with Two-way Short Message Service Reminders in Sickle Cell Disease and Asthma. A feasibility randomized controlled trial.
Pernell BM; DeBaun MR; Becker K; Rodeghier M; Bryant V; Cronin RM
Appl Clin Inform; 2017 May; 8(2):541-559. PubMed ID: 28536723
[TBL] [Abstract][Full Text] [Related]
12. Higher hydroxyurea adherence among young adults with sickle cell disease compared to children and adolescents.
Reddy PS; Cai SW; Barrera L; King K; Badawy SM
Ann Med; 2022 Dec; 54(1):683-693. PubMed ID: 35234095
[TBL] [Abstract][Full Text] [Related]
13. A Medication Adherence App for Children With Sickle Cell Disease: Qualitative Study.
Curtis K; Lebedev A; Aguirre E; Lobitz S
JMIR Mhealth Uhealth; 2019 Jun; 7(6):e8130. PubMed ID: 31215518
[TBL] [Abstract][Full Text] [Related]
14. Study protocol for a randomized controlled trial to assess the feasibility of an open label intervention to improve hydroxyurea adherence in youth with sickle cell disease.
Smaldone A; Findley S; Bakken S; Matiz LA; Rosenthal SL; Jia H; Matos S; Manwani D; Green NS
Contemp Clin Trials; 2016 Jul; 49():134-42. PubMed ID: 27327779
[TBL] [Abstract][Full Text] [Related]
15. Development and evaluation of iManage: A self-management app co-designed by adolescents with sickle cell disease.
Crosby LE; Ware RE; Goldstein A; Walton A; Joffe NE; Vogel C; Britto MT
Pediatr Blood Cancer; 2017 Jan; 64(1):139-145. PubMed ID: 27574031
[TBL] [Abstract][Full Text] [Related]
16. Beliefs about hydroxyurea in youth with sickle cell disease.
Badawy SM; Thompson AA; Liem RI
Hematol Oncol Stem Cell Ther; 2018 Sep; 11(3):142-148. PubMed ID: 29397333
[TBL] [Abstract][Full Text] [Related]
17. Evaluating Perspectives of a Smartphone Medication Application in the Adolescent and Young Adult Oncology Population: A Qualitative Study.
Belsky JA; Holmes C; Stanek J; Yeager ND; Audino AN
J Adolesc Young Adult Oncol; 2021 Jun; 10(3):282-287. PubMed ID: 32960135
[No Abstract] [Full Text] [Related]
18. Oral Medication Adherence Among Adolescents and Young Adults with Cancer Before and Following Use of a Smartphone-Based Medication Reminder App.
Linder LA; Wu YP; Macpherson CF; Fowler B; Wilson A; Jo Y; Jung SH; Parsons B; Johnson R
J Adolesc Young Adult Oncol; 2019 Apr; 8(2):122-130. PubMed ID: 30307778
[TBL] [Abstract][Full Text] [Related]
19. Allocation of Treatment Responsibility and Adherence to Hydroxyurea Among Adolescents With Sickle Cell Disease.
Creary SE; Modi AC; Stanek JR; Chisolm DJ; O'Brien SH; Nwankwo C; Crosby LE
J Pediatr Psychol; 2019 Nov; 44(10):1196-1204. PubMed ID: 31403687
[TBL] [Abstract][Full Text] [Related]
20. Improved hydroxyurea effect with the use of text messaging in children with sickle cell anemia.
Estepp JH; Winter B; Johnson M; Smeltzer MP; Howard SC; Hankins JS
Pediatr Blood Cancer; 2014 Nov; 61(11):2031-6. PubMed ID: 25132074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
